Regulation of bile duct epithelial injury by hepatic CD71+ erythroid cells.
Cellular immune response
Hepatitis
Hepatology
Mouse models
Journal
JCI insight
ISSN: 2379-3708
Titre abrégé: JCI Insight
Pays: United States
ID NLM: 101676073
Informations de publication
Date de publication:
04 06 2020
04 06 2020
Historique:
received:
17
12
2019
accepted:
29
04
2020
pubmed:
15
5
2020
medline:
19
5
2021
entrez:
15
5
2020
Statut:
epublish
Résumé
Extramedullary hematopoietic cells are present in the liver of normal neonates in the first few days of life and persist in infants with biliary atresia. Based on a previous report that liver genes are enriched by erythroid pathways, we examined the liver gene expression pattern at diagnosis and found the top 5 enriched pathways are related to erythrocyte pathobiology in children who survived with the native liver beyond 2 years of age. Using immunostaining, anti-CD71 antibodies identified CD71+ erythroid cells among extramedullary hematopoietic cells in the livers at the time of diagnosis. In mechanistic experiments, the preemptive antibody depletion of hepatic CD71+ erythroid cells in neonatal mice rendered them resistant to rhesus rotavirus-induced (RRV-induced) biliary atresia. The depletion of CD71+ erythroid cells increased the number of effector lymphocytes and delayed the RRV infection of livers and extrahepatic bile ducts. In coculture experiments, CD71+ erythroid cells suppressed the activation of hepatic mononuclear cells. These data uncover an immunoregulatory role for CD71+ erythroid cells in the neonatal liver.
Identifiants
pubmed: 32407296
pii: 135751
doi: 10.1172/jci.insight.135751
pmc: PMC7308060
doi:
pii:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Video-Audio Media
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIDDK NIH HHS
ID : P30 DK078392
Pays : United States
Références
Nature. 2013 Dec 5;504(7478):158-62
pubmed: 24196717
Cell. 2018 Apr 19;173(3):634-648.e12
pubmed: 29606356
J Hepatol. 2010 May;52(5):718-26
pubmed: 20347178
Nat Med. 2018 Oct;24(10):1536-1544
pubmed: 30297899
J Crohns Colitis. 2019 Feb 1;13(2):230-244
pubmed: 30272151
J Immunol. 2018 Jun 15;200(12):4044-4058
pubmed: 29735482
Sci Rep. 2018 Jan 17;8(1):905
pubmed: 29343773
Sci Transl Med. 2011 Sep 28;3(102):102ra94
pubmed: 21957172
Curr Opin Pediatr. 2015 Jun;27(3):389-94
pubmed: 25944310
PLoS Biol. 2018 Dec 14;16(12):e2006649
pubmed: 30550561
Anat Rec (Hoboken). 2019 May;302(5):818-824
pubmed: 30312024
PLoS Genet. 2013;9(8):e1003696
pubmed: 23966875
J Clin Invest. 2009 Aug;119(8):2281-90
pubmed: 19662681
Am J Surg Pathol. 2016 Dec;40(12):1601-1615
pubmed: 27776008
mBio. 2019 Nov 26;10(6):
pubmed: 31772057
J Hepatol. 2016 Sep;65(3):631-42
pubmed: 27164551
Biomed Res Int. 2015;2015:421413
pubmed: 26064908
Front Immunol. 2014 Aug 12;5:376
pubmed: 25161654
Immunobiology. 2016 Aug;221(8):853-61
pubmed: 27117669
Gastroenterology. 2019 Oct;157(4):1138-1152.e14
pubmed: 31228442
J Immunol. 2017 Sep 15;199(6):2081-2095
pubmed: 28779022
Cell Mol Gastroenterol Hepatol. 2015 May 1;1(3):267-274
pubmed: 26090510
Am J Physiol Gastrointest Liver Physiol. 2008 Jul;295(1):G16-G26
pubmed: 18436621
J Clin Transl Hepatol. 2018 Dec 28;6(4):410-419
pubmed: 30637219
Semin Liver Dis. 2012 Nov;32(4):307-16
pubmed: 23397531
Hepatology. 2014 Jul;60(1):211-23
pubmed: 24493287
Int J Biol Sci. 2012;8(5):719-30
pubmed: 22701342
PLoS One. 2015 Sep 01;10(9):e0136214
pubmed: 26325187
J Clin Pathol. 2013 Feb;66(2):99-108
pubmed: 23162109
J Surg Res. 2012 Oct;177(2):275-81
pubmed: 22785360
Liver Int. 2008 May;28(5):587-8
pubmed: 18433387
Hepatology. 2012 Jul;56(1):219-27
pubmed: 22334397
Gastroenterology. 2007 Jul;133(1):268-77
pubmed: 17631148
Genome Med. 2010 May 13;2(5):33
pubmed: 20465800
Trends Immunol. 2019 Mar;40(3):181-185
pubmed: 30718046
J Hepatol. 2018 Nov;69(5):1136-1144
pubmed: 29886157